Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
February 3, 2023
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
ZYUS Life Sciences Ships Medical Cannabinoid Oil Formulations for Distribution in Australia
July 19, 2022
Ryan Allway July 19th, 2022 News, Top News Shipment marks an important milestone to enable patients in Australia to access ZYUS’ medical cannabinoid oil formulations as part of strategic international expansion SASKATOON, Saskatchewan, July 19, 2022–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a Canadian life sciences company leading scientific research... Read more
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
January 4, 2022
Patent Extends Protection for its Novel Compounds and Methods Already granted in Australia and Japan TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), marks... Read more
SciSparc Awarded Three Patents For Its Novel Compounds and Methods
September 7, 2021
Ryan Allway September 7th, 2021 TEL AVIV, Israel, Sept. 7, 2021 /PRNewswire/ — SciSparc Ltd. (OTC Pink: SPRCF), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), today announced it has been awarded two patents from the Australian Patent... Read more
Ryan Allway June 22nd, 2021 PERTH, Australia, June 22, 2021 /PRNewswire/ — Little Green Pharma Ltd (ASX: LGP) has acquired a world-class, fully-operational, GMP medicinal cannabis cultivation and manufacturing facility in Denmark from Canopy Growth Corporation (TSX:WEED, NASDAQ: CGC). The facility, located in Northern Odense, has the capacity to produce in excess of 12 tonnes per annum of... Read more
Ryan Allway January 23rd, 2019 Exclusive, Top News, Uncategorized Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the... Read more
